Multicentre study encouraging for Spectranetics wire
This article was originally published in Clinica
Results of multicentre study of Spectranetics' 0.018 Prima laser guidewire are "encouraging", according to Professor RWR Simon of Kiel Medical University, Germany. The wire was able to cross total occlusions in 56% of patients. However, perforations occurred in almost a quarter of cases. The perforation led to tamponade in two patients when an angioplasty device was advanced into the free pericardial space.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.